BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, Im E, Jung Y, Yoo J. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res 2020;43:153-69. [DOI: 10.1007/s12272-020-01219-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Zheng X, Chu Q. Bio-based nanomaterials for cancer therapy. Nano Today 2021;38:101134. [DOI: 10.1016/j.nantod.2021.101134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
2 Sharifi-Azad M, Fathi M, Cho WC, Barzegari A, Dadashi H, Dadashpour M, Jahanban-Esfahlan R. Recent advances in targeted drug delivery systems for resistant colorectal cancer. Cancer Cell Int 2022;22:196. [PMID: 35590367 DOI: 10.1186/s12935-022-02605-y] [Reference Citation Analysis]
3 Javed Z, Sadia H, Iqbal MJ, Shamas S, Malik K, Ahmed R, Raza S, Butnariu M, Cruz-Martins N, Sharifi-Rad J. Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment. Cancer Cell Int 2021;21:189. [PMID: 33794890 DOI: 10.1186/s12935-021-01888-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang C, Merlin D. Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy. Nanomaterials (Basel) 2020;10:E1424. [PMID: 32708193 DOI: 10.3390/nano10071424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Bhaskaran NA, Kumar L. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. J Control Release 2021;336:16-39. [PMID: 34118336 DOI: 10.1016/j.jconrel.2021.06.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Naeem M, Lee J, Oshi MA, Cao J, Hlaing SP, Im E, Jung Y, Yoo JW. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis. Acta Biomater 2020;116:368-82. [PMID: 32937207 DOI: 10.1016/j.actbio.2020.09.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
7 Feng K, Wei Y, Hu T, Linhardt RJ, Zong M, Wu H. Colon-targeted delivery systems for nutraceuticals: A review of current vehicles, evaluation methods and future prospects. Trends in Food Science & Technology 2020;102:203-22. [DOI: 10.1016/j.tifs.2020.05.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Oshi MA, Lee J, Naeem M, Hasan N, Kim J, Kim HJ, Lee EH, Jung Y, Yoo J. Curcumin Nanocrystal/pH-Responsive Polyelectrolyte Multilayer Core–Shell Nanoparticles for Inflammation-Targeted Alleviation of Ulcerative Colitis. Biomacromolecules 2020;21:3571-81. [DOI: 10.1021/acs.biomac.0c00589] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
9 Xu Y, Zhu BW, Li X, Li YF, Ye XM, Hu JN. Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh2 for effective treatment of ulcerative colitis. Biomaterials 2022;280:121077. [PMID: 34890974 DOI: 10.1016/j.biomaterials.2021.121077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 De Anda-flores Y, Carvajal-millan E, Campa-mada A, Lizardi-mendoza J, Rascon-chu A, Tanori-cordova J, Martínez-lópez AL. Polysaccharide-Based Nanoparticles for Colon-Targeted Drug Delivery Systems. Polysaccharides 2021;2:626-47. [DOI: 10.3390/polysaccharides2030038] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Fatfat Z, Fatfat M, Gali-Muhtasib H. Micelles as potential drug delivery systems for colorectal cancer treatment. World J Gastroenterol 2022; 28(25): 2867-2880 [DOI: 10.3748/wjg.v28.i25.2867] [Reference Citation Analysis]
12 Aminu N, Bello I, Umar NM, Tanko N, Aminu A, Audu MM. The influence of nanoparticulate drug delivery systems in drug therapy. Journal of Drug Delivery Science and Technology 2020;60:101961. [DOI: 10.1016/j.jddst.2020.101961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Esrafili MD, Khan AA. Alkali metal decorated C60 fullerenes as promising materials for delivery of the 5-fluorouracil anticancer drug: a DFT approach. RSC Adv 2022;12:3948-56. [PMID: 35425459 DOI: 10.1039/d1ra09153k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khotimchenko M. Pectin polymers for colon-targeted antitumor drug delivery. International Journal of Biological Macromolecules 2020;158:1110-24. [DOI: 10.1016/j.ijbiomac.2020.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 9.5] [Reference Citation Analysis]
15 Delasoie J, Schiel P, Vojnovic S, Nikodinovic-Runic J, Zobi F. Photoactivatable Surface-Functionalized Diatom Microalgae for Colorectal Cancer Targeted Delivery and Enhanced Cytotoxicity of Anticancer Complexes. Pharmaceutics 2020;12:E480. [PMID: 32466116 DOI: 10.3390/pharmaceutics12050480] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ng YM, Mat Yusuf SNA, Chiu HI, Lim V. Redox-Sensitive Linear and Cross-Linked Cystamine-Based Polymers for Colon-Targeted Drug Delivery: Design, Synthesis, and Characterisation. Pharmaceutics 2020;12:E461. [PMID: 32443633 DOI: 10.3390/pharmaceutics12050461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Moghadam A, Kariminia S, Mobarakeh MS. Novel pH-responsive polyvinyl alcohol/Arabic gum /magnesium oxide nanobiocomposite for oral colon targeted drug delivery. Journal of Drug Delivery Science and Technology 2022;74:103544. [DOI: 10.1016/j.jddst.2022.103544] [Reference Citation Analysis]
18 Andretto V, Rosso A, Briançon S, Lollo G. Nanocomposite systems for precise oral delivery of drugs and biologics. Drug Deliv Transl Res 2021;11:445-70. [PMID: 33534107 DOI: 10.1007/s13346-021-00905-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Farmanbar N, Mohseni S, Darroudi M. Green synthesis of chitosan-coated magnetic nanoparticles for drug delivery of oxaliplatin and irinotecan against colorectal cancer cells. Polym Bull . [DOI: 10.1007/s00289-021-04066-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yamauchi Y, Doi N, Kondo S, Sasai Y, Kuzuya M. Synthesis and Characterization of Polymer-Linked Prodrug of Antibacterial Agent for The Targeted Delivery to The Colon by Cold Plasma Technique. J Photopol Sci Technol 2020;33:343-8. [DOI: 10.2494/photopolymer.33.343] [Reference Citation Analysis]
22 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 26.0] [Reference Citation Analysis]
23 Prasher P, Sharma M, Mehta M, Satija S, Aljabali AA, Tambuwala MM, Anand K, Sharma N, Dureja H, Jha NK, Gupta G, Gulati M, Singh SK, Chellappan DK, Paudel KR, Hansbro PM, Dua K. Current-status and applications of polysaccharides in drug delivery systems. Colloid and Interface Science Communications 2021;42:100418. [DOI: 10.1016/j.colcom.2021.100418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
24 Li S, Xu Z, Alrobaian M, Afzal O, Kazmi I, Almalki WH, Altamimi ASA, Al-Abbasi FA, Alharbi KS, Altowayan WM, Singh T, Akhter MH, Gupta M, Rahman M, Beg S. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma. Biotechnol Appl Biochem 2021. [PMID: 34775646 DOI: 10.1002/bab.2279] [Reference Citation Analysis]
25 Zhao QQ, Zhang XY, Tang XF, Qiao H. A novel and oral colon targeted isoliquiritigenin delivery system: Development, optimization, characterization and in vitro evaluation. Journal of Drug Delivery Science and Technology 2021;66:102777. [DOI: 10.1016/j.jddst.2021.102777] [Reference Citation Analysis]
26 Wathoni N, Nguyen AN, Rusdin A, Umar AK, Mohammed AFA, Motoyama K, Joni IM, Muchtaridi M. Enteric-Coated Strategies in Colorectal Cancer Nanoparticle Drug Delivery System. Drug Des Devel Ther 2020;14:4387-405. [PMID: 33116423 DOI: 10.2147/DDDT.S273612] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kaur J, Gulati M, Gowthamarajan K, Vishwas S, Kumar Chellappan D, Gupta G, Dua K, Pandey NK, Kumar B, Singh SK. Combination therapy of vanillic acid and oxaliplatin co-loaded in polysaccharide based functionalized polymeric micelles could offer effective treatment for colon cancer: A hypothesis. Med Hypotheses 2021;156:110679. [PMID: 34555619 DOI: 10.1016/j.mehy.2021.110679] [Reference Citation Analysis]
28 Li S, Zhang H, Chen K, Jin M, Vu SH, Jung S, He N, Zheng Z, Lee MS. Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges. Drug Deliv 2022;29:1142-9. [PMID: 35384787 DOI: 10.1080/10717544.2022.2058646] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Cabeza L, Perazzoli G, Mesas C, Jiménez-Luna C, Prados J, Rama AR, Melguizo C. Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents. AAPS PharmSciTech 2020;21:178. [PMID: 32591920 DOI: 10.1208/s12249-020-01731-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
30 Chavda VP, Vihol D, Mehta B, Shah D, Patel M, Vora LK, Pereira-Silva M, Paiva-Santos AC. Phytochemical-loaded liposomes for anticancer therapy: an updated review. Nanomedicine (Lond) 2022. [PMID: 35259920 DOI: 10.2217/nnm-2021-0463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zhang P, Li Y, Tang W, Zhao J, Jing L, Mchugh KJ. Theranostic nanoparticles with disease-specific administration strategies. Nano Today 2022;42:101335. [DOI: 10.1016/j.nantod.2021.101335] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
32 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Vitulo M, Gnodi E, Meneveri R, Barisani D. Interactions between Nanoparticles and Intestine. IJMS 2022;23:4339. [DOI: 10.3390/ijms23084339] [Reference Citation Analysis]
34 Oshi MA, Lee J, Kim J, Hasan N, Im E, Jung Y, Yoo JW. pH-Responsive Alginate-Based Microparticles for Colon-Targeted Delivery of Pure Cyclosporine A Crystals to Treat Ulcerative Colitis. Pharmaceutics 2021;13:1412. [PMID: 34575488 DOI: 10.3390/pharmaceutics13091412] [Reference Citation Analysis]
35 Tie S, Tan M. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols. J Agric Food Chem . [DOI: 10.1021/acs.jafc.1c05012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
36 Zhang J, Liu X, Lin J, Bao X, Peng J, Gong Z, Luan X, Chen Y. Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121979] [Reference Citation Analysis]
37 Chen Y, Du F, Tang L, Xu J, Zhao Y, Wu X, Li M, Shen J, Wen Q, Cho CH, Xiao Z. Carboranes as unique pharmacophores in antitumor medicinal chemistry. Mol Ther Oncolytics 2022;24:400-16. [PMID: 35141397 DOI: 10.1016/j.omto.2022.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Dhumad AM, Majeed HJ, Zandi H, Harismah K. FeC19 cage vehicle for fluorouracil anticancer drug delivery: DFT approach. Journal of Molecular Liquids 2021;333:115905. [DOI: 10.1016/j.molliq.2021.115905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]